Vesicare and Volvulus - a phase IV clinical study of FDA data

Summary:

Volvulus is reported as a side effect among people who take Vesicare (solifenacin succinate), especially for people who are female, 50-59 old, also take Evening Primrose, and have Bladder disorder.

The phase IV clinical study analyzes which people have Volvulus when taking Vesicare. It is created by eHealthMe based on reports of 29,875 people who have side effects when taking Vesicare from the FDA, and is updated regularly.

What is Vesicare?

Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. eHealthMe is studying from 30,656 Vesicare users. Check the latest studies of Vesicare.

What is Volvulus?

Volvulus (obstruction caused by twisting of the stomach or intestine) is found to be associated with 280 drugs and 374 conditions by eHealthMe. Check the latest studies of Volvulus.

On Jul, 05, 2026

29,875 people reported to have side effects when taking Vesicare.
Among them, 12 people (0.04%) have Volvulus.

Among these 12 people:

What is the gender of people who have Volvulus when taking Vesicare? *

female: 100 %
male: 0.0 %

What is the age of people who have Volvulus when taking Vesicare? *

What are other drugs people take besides Vesicare? *

What are other side effects people have besides Volvulus? *

Abdominal Adhesions (inflammation of abdomen): 5 people, 41.67%
Pneumonia: 2 people, 16.67%
Haemorrhage Subcutaneous (bleeding from skin): 2 people, 16.67%
Corynebacterium Infection (infection by corynebacterium (diphtheria)): 1 person, 8.33%
Adhesion: 1 person, 8.33%
Altered State Of Consciousness (altered state of mind): 1 person, 8.33%
Arrhythmias (irregular heartbeat): 1 person, 8.33%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 8.33%
Clostridium Colitis (inflammation of colon by clostridium difficile bacteria infection): 1 person, 8.33%
Confusional State: 1 person, 8.33%

What are the existing conditions these people have? *

Seasonal Allergy (allergic condition due to certain season): 6 people, 50.00%
Pain: 6 people, 50.00%
Fibromyalgia (a long-term condition which causes pain all over the body): 6 people, 50.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 6 people, 50.00%
Bladder Disorder: 6 people, 50.00%
Fungal Infection: 2 people, 16.67%
Angina Unstable (chest pain due to ischemia of the heart muscle- unstable): 2 people, 16.67%
Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 8.33%
Parkinson's Disease: 1 person, 8.33%
Neuralgia (pain in one or more nerves): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Vesicare and have Volvulus?

- Check whether Volvulus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vesicare:

Vesicare (30,656 reports)

Volvulus treatments and more:

Volvulus (2,613 reports)

Browse all side effects of Vesicare:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Volvulus:

Volvulus (280 drugs)

Browse all the conditions that are associated with Volvulus:

Volvulus (374 conditions)

Related publications that referenced our studies

Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .
Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on solifenacin succinate (the active ingredients of Vesicare) and Vesicare (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.